Literature DB >> 35846418

68Ga-DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT.

Akram Al-Ibraheem1,2, Deya' Aldeen Sweedat1, Farah Anwer1,3, Feras Istatieh1, Malik E Juweid2.   

Abstract

68Ga-labeled somatostatin receptor analogs physiologic distribution patterns have become recognizable among nuclear medicine physicians because of the increasing routine clinical use of this modality in the work-up of neuroendocrine tumors. Some pitfalls during 68Ga-labeled somatostatin receptor PET/CT have recently been reported as causes of misdiagnoses. Iatrogenic microembolism as a cause of 18F-FDG embolus is well-established; however, 68Ga-DOTATOC embolus is not well documented in the literature. In the current case, the presence and the spontaneous resolution of the 68Ga-labeled somatostatin receptor analogs embolus during sequential PET/CT are nicely demonstrated. Awareness of this incidental finding would avoid misdiagnosis and unnecessary investigations.
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2022.

Entities:  

Keywords:  68Ga-labeled somatostatin receptor analogs; Embolus; PET/CT; Pulmonary microembolism

Year:  2022        PMID: 35846418      PMCID: PMC9276866          DOI: 10.1007/s13139-022-00752-8

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  7 in total

1.  Distribution pattern of 68Ga-DOTATATE in disease-free patients.

Authors:  Manu Shastry; Irfan Kayani; Damian Wild; Martyn Caplin; Dimitris Visvikis; Svetislav Gacinovic; Jean Claude Reubi; Jamshed B Bomanji
Journal:  Nucl Med Commun       Date:  2010-12       Impact factor: 1.690

2.  68Ga-DOTANOC Focal Pulmonary Activity With No Corresponding CT Abnormality.

Authors:  Emmanouil Panagiotidis; Nagabhushan Seshadri; Rashika Fernando; Priya Healey; Sobhan Vinjamuri
Journal:  Clin Nucl Med       Date:  2016-12       Impact factor: 7.794

3.  Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

Authors:  Akram Al-Ibraheem; Ralph Alexander Bundschuh; Johannes Notni; Andreas Buck; Anna Winter; Hans-Jürgen Wester; Markus Schwaiger; Klemens Scheidhauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-27       Impact factor: 9.236

4.  18F-FDG PET/CT lung 'focalities' without coregistered CT findings: an interpretative clinical dilemma.

Authors:  Sotirios Chondrogiannis; Maria Cristina Marzola; Gaia Grassetto; Alessio Zorzi; Elisa Milan; Lucia Rampin; Domenico Rubello; Patrick M Colletti
Journal:  Nucl Med Commun       Date:  2015-04       Impact factor: 1.690

5.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Authors:  Michael S Hofman; W F Eddie Lau; Rodney J Hicks
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

6.  68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report.

Authors:  Aysar Khalaf; Nader Hirmas; Farah Anwer; Akram Al-Ibraheem
Journal:  Nucl Med Mol Imaging       Date:  2020-07-06

7.  Physiological Biodistribution of 68Ga-DOTA-TATE in Normal Subjects

Authors:  Salih Özgüven; Nuh Filizoğlu; Selin Kesim; Kevser Öksüzoğlu; Feyza Şen; Tunç Öneş; Sabahat İnanır; Halil Turgut Turoğlu; Tanju Yusuf Erdil
Journal:  Mol Imaging Radionucl Ther       Date:  2021-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.